The Reproductive Medicine Network (RMN), established in 1989 and funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), is a cooperative effort of six clinical sites, a data coordinating center, and the Fertility and Infertility (FI) Branch of the NICHD, charged with conducting and publishing high quality clinical studies in reproductive medicine.

What is the Reproductive Medicine Network?

Disorders of the reproductive system in women and men have both a public health and economic impact. For those people who are dealing with infertility issues, the out of pocket cost can be astronomical. Treatment for reproductive system disorders such as endometriosis or fibroids may result in the loss of childbearing potential. Relatively few interventions and treatments for these disorders have been subjected to rigorous scientific evaluation.

The long-term objective of the Reproductive Medicine Network is to improve the care of women and men with disorders affecting the reproductive system by conducting controlled clinical trials of selected diagnostic and therapeutic interventions. Funding for this research is provided by the National Institutes of Health through the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).

There are six research centers located across the United States.

Yale Collaborative Center for Statistics in Science (C²S²), New Haven, Connecticut, coordinates the clinical trials for the Reproductive Medicine Network. At this time, there are two active protocols. For more information about our studies go to RMN Studies.

For more information visit the NICHD section on Reproductive Medicine.